About Index Trending news
Analyze
Pricing
Mersana Therapeutics

Mersana Therapeutics

Work at Mersana Therapeutics? Add yourself to this profile

Mersana Therapeutics

Rewriting the rules for immunoconjugate therapies.
Edit Profile
More info

Elsewhere

Contributors to this profile

Also headquartered in Cambridge

MIT MIT Raspberry Pi Raspberry Pi ARM ARM Xconomy Xconomy Mobile.co Mobile.co HubSpot HubSpot nuTonomy nuTonomy Biogen Biogen General Catalyst General Catalyst Harvard University Harvard University

Companies in the same industry

Complexa Complexa Clearside BioMedical, Inc. Clearside BioMedical, Inc. CoDa Therapeutics, Inc. CoDa Therapeutics, Inc. 3-V Biosciences 3-V Biosciences Pinteon Therapeutics Inc. Pinteon Therapeutics Inc. Allinaire Therapeutics Allinaire Therapeutics Vividion Therapeutics Vividion Therapeutics Atterx Biotherapeutics Atterx Biotherapeutics ArGEN-X ArGEN-X Marina Biotech Marina Biotech

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2
Add info
Latest funding
IPO
$75,000,000
Venture capital (Series C)
$33,000,000
Wellington Management, Rock Springs Capital, Arrowpoint Partners, +3
Employees

Unknown size

Locations
HQ
Cambridge, United States
Headquarters
$75,000,000 IPO
PE Hub

VC-backed Mersana Therapeutics debuts IPO

Stock markets Health
Mersana Therapeutics
Mersana Therapeutics
$33,000,000 Venture capital (Series C)
biospace , mersana

Booming Mersana Nabs Another 33 Million for a Total Take of 120 Million

Health Funding
Mersana Therapeutics
Mersana Therapeutics